Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02223819
Brief Title: Crizotinib in High-Risk Uveal Melanoma Following Definitive Therapy

First Submitted : August 20, 2014
First Submitted that Met QC Criteria : August 20, 2014
First Posted : August 22, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : March 18, 2021
Last Update Posted : March 19, 2021